ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Feinstein Institutes researchers use novel imaging technology to study how the brain and body communicate

Bioelectronic medicine researchers at The Feinstein Institutes for Medical Research have developed a new method for studying neural signals transmitted to the brain through the vagus nerve – the nerve that helps controls functions like heart rate, breathing and immune response. By using calcium imaging technology to monitor neural activity from a cluster of neurons near the base of the skull, scientists hope to discover new clues about how the body communicates with the brain.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230321005739/en/

Dr. Eric Chang led the new research. (Credit: Feinstein Institutes)

Dr. Eric Chang led the new research. (Credit: Feinstein Institutes)

In a new paper titled “Calcium imaging and analysis of the jugular-nodose ganglia enables identification of distinct vagal sensory neuron subsets,” published in the Journal of Neural Engineering, investigators focused their attention on sensory neurons of the peripheral nervous system (PNS). They wanted to know how these neurons encode and interpret different stimuli in the form of neural activity.

The researchers used imaging of the intact jugular-nodose ganglion – which contains the sensory neurons of the vagus nerve – to directly record neural activity in mice with genetically-encoded calcium indicators. They then analyzed the signals and used a machine learning algorithm to classify the neuronal responses to different types of chemical stimuli applied to the vagus nerve. They found that specific neuronal responses were closely associated with certain types of stimuli, reflecting an encoding of information within the PNS, before further transmission to the brain.

Led by Eric H. Chang, PhD, and postdoctoral researcher Tomás S. Huerta, PhD, the study is part of a multi-year $1.3 million grant from the National Institutes of Health (NIH) to examine how immune signals are transmitted to the brain through the vagus nerve.

“By directly monitoring populations of neurons as they respond to different types of stimuli on the vagus nerve, we begin to see how a diverse range of sensory information can be detected and encoded by these neurons,” said Dr. Chang, assistant professor in the Institute of Bioelectronic Medicine at the Feinstein Institutes. “The information we learn from decoding these signals will help us understand how the vagus nerve communicates with the brain to control many vital physiological functions including respiration, sickness responses and the regulation of inflammation.”

The vagus nerve is often referred to as the body’s superhighway – it connects the brain with all major organs, and controls functions like heart rate, breathing and gastrointestinal function. When the nerve is stimulated, it can reduce inflammation, which is a trigger for many diseases, and help the body’s immune system.

Inflammation is an important immune response, however if uncontrolled, can lead to serious conditions such as Crohn’s disease, rheumatoid arthritis and other chronic inflammatory disorders. In this new study, Feinstein Institutes’ bioelectronic medicine researchers look at how sensory neurons encode and transmit these important physiological signals in the form of neural activity. This information can be used for future research to develop new bioelectronic medicine devices, like vagus nerve stimulators, and better advance our methods to control the signals between the brain and body.

“Dr. Chang’s research enables us to visualize how the vagus nerve processed information before sending it up to the brain,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research. “This is a fascinating new way to think about how the nervous system receives information about the status of inflammation and infection in the body.”

The Feinstein Institutes for Medical Research is the global scientific home of bioelectronic medicine, which combines molecular medicine, neuroscience and biomedical engineering. At the Feinstein Institutes, medical researchers use modern technology to develop new device-based therapies to treat disease and injury.

Built on years of research in molecular mechanisms of disease and the link between the nervous and immune systems, our researchers discover neural targets that can be activated or inhibited with neuromodulation devices, like vagus nerve implants, to control the body’s immune response and inflammation. If inflammation is successfully controlled, diseases – such as arthritis, pulmonary hypertension, Crohn's disease, inflammatory bowel diseases, diabetes, cancer and autoimmune diseases – can be treated more effectively.

Beyond inflammation, using novel brain-computer interfaces, our researchers developed techniques to bypass injuries of the nervous system so that people living with paralysis can regain sensation and use their limbs. By producing bioelectronic medicine knowledge, disease and injury could one day be treated with our own nerves without costly and potentially harmful pharmaceuticals.

About the Feinstein Institutes

The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.56
+0.02 (0.01%)
AAPL  274.61
+0.50 (0.18%)
AMD  209.17
+1.59 (0.77%)
BAC  54.81
-0.52 (-0.94%)
GOOG  307.73
-1.59 (-0.51%)
META  657.15
+9.64 (1.49%)
MSFT  476.39
+1.57 (0.33%)
NVDA  177.72
+1.43 (0.81%)
ORCL  188.65
+3.73 (2.02%)
TSLA  489.88
+14.57 (3.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.